Carregant...
Maximal testosterone suppression in the management of recurrent and metastatic prostate cancer
INTRODUCTION: Testosterone suppression, or androgen-deprivation therapy (ADT), is an established treatment for recurrent and metastatic prostate cancer (PCa). Based on the accuracy and sensitivity of early assays (c. 1960–1970), the castrate testosterone level was set at ≤1.7 nmol/l. Improved sensit...
Guardat en:
| Publicat a: | Can Urol Assoc J |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Canadian Medical Association
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5403681/ https://ncbi.nlm.nih.gov/pubmed/28443139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.4303 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|